Contact Us
 
Drug Info Links PDA Software Article Summaries Slide Shows Review Articles What's New






Therapy
Please Select:
 
   Hemostatic Drug Info
   Interesting Links
   PDA Software
   Article Summaries
   Slide Shows
   Review Articles
   What's New
   Disclaimer

Search the site

Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinux.
Unexpected bleeding disorders: Algorithm for approach to therapy.
Inhibitor antibodies to factor VIII and factor IX: management.
New products for managing inhibitors to coagulation factors: a focus on recombinant factor VIIa concentrate.
     
© Copyright 2002-2018 ~ DocMD.com. All rights reserved.